Peripheral Artery Disease (PAD)

This channel includes news, interventions, and new technology innovations for peripheral artery diease, PAD and critical limb ischemia. 

Intact Vascular Announces $20 Million Series C Financing
News | Stents Peripheral | April 27, 2018

April 27, 2018 — Intact Vascular Inc. recently closed a Series C financing totaling $20 million. This financing is...

Critical Limb Ischemia Treatment Shows No Improvement at Three Months
News | Peripheral Artery Disease (PAD) | March 23, 2018

March 23, 2018 — Patients with foot ulcers or gangrene who received the...

The Xarelto booth at ACC.18

The Xarelto booth at the 2018 American College of Cardiology meeting. 

News | Antiplatelet and Anticoagulation Therapies | March 14, 2018

March 14, 2018 — A late-breaking analysis of the landmark COMPASS study presented at the American College of...

FDA Clears Corindus CorPath GRX for Peripheral Vascular Interventions
Technology | Peripheral Artery Disease (PAD) | February 20, 2018

February 20, 2018 — Corindus Vascular Robotics Inc. announced today that it received 510(k) clearance from the U.S....

In.Pact Admiral Balloon Demonstrates Consistent, Durable Outcomes in LINC 2018 Studies
News | Drug-Eluting Balloons | February 07, 2018

February 7, 2018 — Medtronic plc recently added to its body of clinical evidence supporting the In.Pact Admiral...

Teleflex Launches Next-Generation Sympro Elite and Expro Elite Snares
Technology | Cath Lab | February 07, 2018

February 7, 2018 — Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U...

The Gore TAG stent graft used in TEVAR aortic repair procedures for aneurysms.

The Gore TAG stent graft used for endovascular aortic aneurysm repair procedures.

Feature | Endovascular Aortic Repair | February 05, 2018 | Andrei Churyla, M.D., S. Chris Malaisrie, M.D.

Here are several considerations for physicians when choosing...

12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018

February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s...

LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018

February 1, 2018 –  LimFlow SA, developer of minimally-...

Medtronic Launches IDE Study of Abre Venous Self-Expanding Stent
News | Venous Therapies | January 26, 2018

January 26, 2018 – Medtronic plc announced the initiation of its investigational device exemption (IDE) study for...

Cardiovascular Systems Expands Product Portfolio for Peripheral and Coronary Interventions
News | Balloon Catheter | January 24, 2018

January 24, 2018 — Cardiovascular Systems Inc. recently announced two new partnerships broadening the company’s...

Avinger Announces Treatment of First Patients With Next-Generation Pantheris
News | Atherectomy Devices | January 09, 2018

January 9, 2018 – Avinger Inc. announced that Arne Schwindt, M.D., a vascular surgeon at St. Franziskus Hospital in...

News | Peripheral Artery Disease (PAD) | December 29, 2017

December 29, 2017 — iVascular announced the release of the new Oceanus 14 Pro percutaneous transluminal angioplasty...

The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA atherectomy system. Athar Ansari, M.D.

The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA system. 

Feature | Cath Lab | November 24, 2017 | Athar Ansari, M.D., FACC

As debates about the current state and future of healthcare rage in Congress, the media and healthcare settings...

Overlay Init